| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/25/2012 | EP2078083B1 A novel canine influenza virus and vaccine therefore |
| 04/25/2012 | EP2059534B1 Engineered anti-il-23p19 antibodies |
| 04/25/2012 | EP2004225B1 Regimens for immunisation with meningococcal conjugates |
| 04/25/2012 | EP1996715B1 Bacterial antigens and uses thereof |
| 04/25/2012 | EP1716173B1 Carcinoembryonic antigen fusion protein and uses thereof |
| 04/25/2012 | EP1685152B1 Il-18 binding proteins |
| 04/25/2012 | EP1450859B1 Methods and compositions for the diagnosis of asthma |
| 04/25/2012 | EP1416970B1 Conjugate |
| 04/25/2012 | EP1383490B1 Combination of an epothilone analog and chemotherapeutic agents for the treatment of proliferative diseases |
| 04/25/2012 | EP1379551B1 Adp-ribosylating bacterial toxins |
| 04/25/2012 | EP1112084B2 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 04/25/2012 | CN1956730B Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof, and therapeutic uses thereof |
| 04/25/2012 | CN1921878B 属于Bcl-2家族的蛋白和其片段,和它们在癌症患者中的用途 Belonging to the Bcl-2 family of proteins and their fragments, and their use in cancer patients |
| 04/25/2012 | CN1887348B 鸡志贺氏菌灭活铝胶疫苗及其研制方法 Chicken Shigella inactivated vaccine and the development of methods alhydrogel |
| 04/25/2012 | CN1805758B Nucleotide and cellular vaccine composition |
| 04/25/2012 | CN1788018B Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS 06 of pseudomonas aeruginosa |
| 04/25/2012 | CN1768078B Antibodies directed against hepatitis c virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
| 04/25/2012 | CN1537014B HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases |
| 04/25/2012 | CN102428105A Antibodies containing therapeutic tpo/epo mimetic peptides |
| 04/25/2012 | CN102428102A 诱导XAGE-1b特异性免疫反应的肽及其利用 XAGE-1b induced peptide-specific immune responses and their use |
| 04/25/2012 | CN102428101A 用于治疗用途的方法 A method for therapeutic use |
| 04/25/2012 | CN102427827A 鸟类中增强的免疫应答 An enhanced immune response in birds |
| 04/25/2012 | CN102427826A Adjuvanting Meningococcal Factor H Binding Protein |
| 04/25/2012 | CN102423304A N-2-羟丙基三甲基氯化铵壳聚糖/n,o-羧甲基壳聚糖新城疫减毒活疫苗纳米粒的制备方法 N-2- hydroxypropyl trimethyl ammonium chloride chitosan / n, o- carboxymethyl chitosan preparation of live attenuated Newcastle disease vaccine nanoparticles |
| 04/25/2012 | CN101880647B 重组猪霍乱沙门氏菌及二价基因工程疫苗与应用 Recombinant Salmonella choleraesuis and bivalent vaccines and application of genetic engineering |
| 04/25/2012 | CN101830985B 肠出血性大肠杆菌O157:H7Tir与Tccp的重组蛋白 EHEC O157: H7Tir and Tccp recombinant protein |
| 04/25/2012 | CN101818132B Construction of chimeric rabies strain rLEP333Q-L(H) and research on biological function thereof |
| 04/25/2012 | CN101766815B 紫杉醇及多西紫杉醇的用途 Paclitaxel and docetaxel use |
| 04/25/2012 | CN101745104B 含有复合佐剂的结核亚单位疫苗 Tuberculosis subunit vaccine containing a complex adjuvant |
| 04/25/2012 | CN101658667B 微小隐孢子虫双价蛋白疫苗及其制备方法 Cryptosporidium parvum bivalent protein vaccine and its preparation method |
| 04/25/2012 | CN101607984B 一种多拷贝多肽及其应用 A multi-copy peptide and its application |
| 04/25/2012 | CN101353663B 一种抗i型糖尿病融合蛋白及其制备方法 An anti-i fusion protein of Diabetes and its preparation method |
| 04/25/2012 | CN101128217B 改良的痘病毒快速诱导抗痘病毒或其它传染物的免疫力的用途 Improved rapid induction of immunity to smallpox virus uses acne viruses or other infectious agents |
| 04/25/2012 | CN101102794B 抗sars-冠状病毒的组合物及其应用 Anti-sars- coronavirus composition and application |
| 04/25/2012 | CN101069744B 流感疫苗组合物 Influenza vaccine composition |
| 04/24/2012 | US8163886 such as recombinant proteins (biodrugs) made via engineered host cells; using polymers solubilizable under a given set of conditions |
| 04/24/2012 | US8163885 Humanized antibodies against human interferon-alpha |
| 04/24/2012 | US8163884 Interleukin-21 receptor binding proteins |
| 04/24/2012 | US8163882 Polypeptide variants with altered effector function |
| 04/24/2012 | US8163876 DNA sequences, vectors and proteins of avian influenza hemagglutinin |
| 04/24/2012 | US8163712 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 04/24/2012 | US8163557 Chimaeric human papillomavirus 16 L1 virus-like particles and a method for preparing the particles |
| 04/24/2012 | US8163550 Enhancement of immune responses by 4-1BB-binding agents |
| 04/24/2012 | US8163548 Recombinant bicistronic flaviviruses and methods of use thereof |
| 04/24/2012 | US8163547 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 04/24/2012 | US8163545 Vaccine against pandemic strains of influenza viruses |
| 04/24/2012 | US8163544 Methods and compositions for increasing tissue tropism of recombinant adenoviral vectors |
| 04/24/2012 | US8163542 Potent combinations of mRNA transport elements |
| 04/24/2012 | US8163533 Methods and compositions for combinatorial-based production of multivalent recombinant antigens |
| 04/24/2012 | US8163531 Purification of vaccinia viruses using hydrophobic interaction chromatography |
| 04/24/2012 | US8163530 Nucleic acids encoding respiratory syncytial virus subgroup B strain 9320 |
| 04/24/2012 | US8163519 Fungal immunomodulatory protein (FIP) prepared by microorganisms and uses thereof |
| 04/24/2012 | US8163494 Method for assessing metastatic properties of breast cancer |
| 04/24/2012 | US8163476 CUDR as biomarker for cancer progression and therapeutic response |
| 04/24/2012 | US8163297 Live attenuated aldolase-negative bacterial vaccine |
| 04/24/2012 | US8163296 Dimensional analysis of saccharide conjugates with GPC and SEC-MALS |
| 04/24/2012 | US8163295 Outer membrane vesicles and uses thereof |
| 04/24/2012 | US8163294 Growth regulatable recombinant BCG compositions |
| 04/24/2012 | US8163293 Modified Vaccinia Virus Ankara for the vaccination of neonates |
| 04/24/2012 | US8163292 Herpes simplex viruses and methods of viral replication |
| 04/24/2012 | US8163291 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| 04/24/2012 | US8163290 Glycolipids and analogues thereof as antigens for NKT cells |
| 04/24/2012 | US8163289 Methods and compositions involving polymeric immunoglobulin fusion proteins |
| 04/24/2012 | US8163288 S. aureus polypeptides and antibodies |
| 04/24/2012 | US8163287 Combination therapy of her expressing tumors |
| 04/24/2012 | US8163286 Anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
| 04/24/2012 | US8163285 Nogo-A binding molecules and pharmaceutical use thereof |
| 04/24/2012 | US8163284 Methods of treating TSLP-related inflammatory disorders |
| 04/24/2012 | US8163283 Monoclonal antibodies against gonadotropin-releasing hormone receptor |
| 04/24/2012 | US8163281 Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis |
| 04/24/2012 | US8163280 Antibodies to c-Met |
| 04/24/2012 | US8163279 IL3Rα antibody conjugates and uses thereof |
| 04/24/2012 | US8163269 Bioactive stents for type II diabetics and methods for use thereof |
| 04/24/2012 | CA2542834C Conjugates or co-administration of igf-1 receptor ligands with anti-cancer chemotherapeutic agents |
| 04/24/2012 | CA2501757C Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents |
| 04/24/2012 | CA2485959C Polypeptide cleavage process |
| 04/24/2012 | CA2457011C Treatment of glial tumors with glutamate antagonists |
| 04/24/2012 | CA2452447C Antagonistic anti-htnfsf13b human antibodies |
| 04/24/2012 | CA2443391C Pharmaceutical composition of f(ab)2 antibody fragments and a process for the preparation thereof |
| 04/24/2012 | CA2339529C Isolated and purified human soluble guanylyl cyclase .alpha.1/.beta.1 (hsgc .alpha.1/.beta.1) |
| 04/24/2012 | CA2277141C Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure |
| 04/24/2012 | CA2239072C Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis |
| 04/19/2012 | WO2012051491A1 Compositions and methods for controlling neurotropic viral pathogenesis by micro-rna targeting |
| 04/19/2012 | WO2012051372A2 Immunoreactive antigens of mycoplasma heamofelis and diagnostic immunoassay |
| 04/19/2012 | WO2012051291A1 Targeting antigens to human dendritic cells via dc-asialoglycoprotein receptor to produce il-10 regulatory t cells |
| 04/19/2012 | WO2012051211A2 Antigen delivery platforms |
| 04/19/2012 | WO2012051207A2 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsup90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS |
| 04/19/2012 | WO2012051111A2 Human oncostatin m antibodies and methods of use |
| 04/19/2012 | WO2012051097A1 Methods and compositions for inducing a t-cell response to plasmodium species |
| 04/19/2012 | WO2012050944A2 Methods of treating chronic prostatitis/chronic pelvic pain syndrome |
| 04/19/2012 | WO2012050893A2 Immunogenic polypeptides having an immunogenic scaffold protein and a loop peptide, presenting a 3074- or 2219/2557- monoclonal antibody-targeted epitope, which is present in the hiv gp120 protein |
| 04/19/2012 | WO2012050874A2 Targeting heme for the treatment of immune mediated inflammatory diseases |
| 04/19/2012 | WO2012050229A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses |
| 04/19/2012 | WO2012050193A1 Ebola virus liposome vaccine |
| 04/19/2012 | WO2012050154A1 Inhibitor of osteoclast formation containing anti-vdac antibody |
| 04/19/2012 | WO2012049654A1 Bacterial ribonucleic acid cell wall compositions and methods of making and using them |
| 04/19/2012 | WO2012049431A2 Use of an anti-cd20 antibody for treating primary cerebral lymphoma |
| 04/19/2012 | WO2012049366A1 Norovirus capsid and rotavirus vp6 protein for use as combined vaccine |
| 04/19/2012 | WO2012049317A2 Novel antigen |
| 04/19/2012 | WO2012049312A1 Suppression of a type 1 hypersensitivity immune response with an unrelated antigen |